Answers are grounded in this paper and cite their sources.
Background: Gallbladder cancer (GBC) is an aggressive biliary tract malignancy with few targeted therapies. Though efforts have been made to identify actionable alterations and potential targeted strategies for GBC, its metabolic landscape and dependencies remain incompletely defined. Methods: We performed untargeted metabolomic profiling of 27 paired GBC tissues and adjacent nontumor tissues and integrated these data with public transcriptomic cohorts and DepMap CRISPR dependency data to characterize metabolic alterations and vulnerabilities in GBC. Additionally, we analyzed a single-cell RNA-sequencing (scRNA-seq) dataset to elucidate the potential biological role of glycerol-3-phosphate dehydrogenase 2 (GPD2). Results: The multi-omic integration revealed obvious metabolic remodeling in GBC, including enhanced lipid biosynthesis and hexosamine biosynthetic pathway activity within the carbon metabolic network, together with polyamine accumulation. The DepMap-based dependency analysis prioritized solute carrier family 7 member 5 (SLC7A5) and succinate dehydrogenase complex iron sulfur subunit B (SDHB) as clinically relevant metabolic vulnerabilities. Among all the metabolites, glycerol 3-phosphate (Gro3P) was the most depleted, in parallel with the accumulation of dihydroxyacetone phosphate (DHAP) and the reciprocal expression of glycerol-3-phosphate shuttle (G3PS) enzyme genes, which was correlated with poor overall survival. The functional experiments showed that GPD2 knockdown unexpectedly enhanced primary tumor growth in a subcutaneous xenograft model. However, the scRNA-seq analysis and the cell migration assays linked GPD2 to a metastasis-associated epithelial state and tumor-cell motility. Conclusions: This study characterizes the metabolic landscape of GBC and reveals an uncoupled G3PS marked by Gro3P depletion. GPD2 expression is associated with a metastasis-related malignant epithelial state and poor prognosis, while GPD2 knockdown reduces cell migration in vitro. These findings warrant the further investigation of GPD2 in GBC progression, but its role in metastatic dissemination and its therapeutic implications remain to be established.
No takes yet. Share an insight, caveat, or question.
潘裕仁 et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: